港股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

醫美概念股

869.902

-13.531-1.53%

漲家數：1

跌家數：12

平家數：- -

市盈率：- -

高：884.356

開：882.809

低：858.346

收：883.433

成交量：6,996.06萬

成交額：7.10億

市值：1,445.98億

流通市值：1,067.35億

資料載入中...

雲南瑞麗產業協作園區隴川片區交出亮眼「成績單」

時代天使(06699)授出合共156.39萬份受限制股份單位

智通财经网

復星醫藥(02196.HK)周五斥2,186萬元回購134萬股

阿斯达克财经

復星醫藥(600196.SH)子公司地舒單抗生物類似藥HLX14註冊申請獲受理

復星醫藥(02196)9月11日斥資約2186.42萬港元回購134萬股

昊海生物科技：9月11日斥資40萬港元回購24300股

南方财经网

瑞麗醫美(02135)股價下跌6.612%，現價港幣$0.113

阿斯达克财经

【券商聚焦】中信建投：醫療器械板塊業績有望逐步改善

【券商聚焦】中信證券：上半年CXO及生命科學上游板塊整體表現穩健，CRO有望量價齊升

三生製藥(01530)9月10日斥資6262.93萬港元回購400萬股

昊海生物科技(06826)9月10日耗資約79.57萬港元回購4.8萬股

昊海生物科技(06826.HK)9月10日耗資約79.57萬港元回購4.8萬股

復星醫藥(02196)股價下跌5.032%，現價港幣$16.42

阿斯达克财经

三生製藥(01530)出現大手賣出56.2萬股，成交價$15.6，涉資876.72萬

阿斯达克财经

四環醫藥(00460)出現大手賣出210萬股，成交價$0.73，涉資153.3萬

阿斯达克财经

多家藥企處置資產反哺主業

復星醫藥白癜風口服新藥獲批III期臨床

復星醫藥(02196)9月9日斥資262.98萬港元回購15.25萬股

康哲藥業(00867.HK)狂犬雙特異性抗體「金速希」全國首批處方落地

阿斯达克财经

《大行》里昂：中國創新藥板塊重返Alpha主導宏觀波動或提供買入機會

阿斯达克财经

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.imtigers.com/hant/stock/BK1593/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BK1593","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1593\",,,,,undefined,":{"symbol":"BK1593","market":"HK","secType":"PLATE","nameCN":"醫美概念股","latestPrice":869.9022,"timestamp":1789114133774,"preClose":883.43335,"halted":0,"volume":69960617,"delay":0,"changeRate":-0.015317,"floatShares":0,"shares":0,"eps":0,"marketStatus":"休市中","change":-13.531128,"latestTime":"09-11 16:00:00","open":882.80945,"high":884.35583,"low":858.3457,"amount":709509713,"amplitude":0.029442,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1789349400000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1789090200000,1789099200000],[1789102800000,1789113600000]],"pbRate":1.117247,"peRate":10.209827,"turnoverRate":0.003127,"increases":1,"decrements":12,"flats":0,"marketCap":144597722624,"floatMarketCap":106735221760},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1593\",,,,,undefined,":{"symbol":"BK1593","high":884.35583,"amplitude":0.029442,"preClose":883.43335,"low":858.3457,"pbRate":"1.117247","latestPrice":869.9022,"volume":69960617,"delay":0,"open":882.80945,"prevYearClose":1094.978,"prevWeekClose":913.749,"prevMonthClose":902.195,"prevQuarterClose":846.145,"fiveDayClose":913.749,"twentyDayClose":957.712,"sixtyDayClose":841.957,"secType":"PLATE","market":"HK","turnoverRate":0.003127,"peRate":10.209827,"marketCap":144597722624,"floatMarketCap":106735221760,"timestamp":1789114133774,"nameCN":"醫美概念股"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1593\",,,,undefined,":{"bkCode":"BK1593","up":1,"down":12,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1593\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2666060135","title":"雲南瑞麗產業協作園區隴川片區交出亮眼「成績單」","url":"https://stock-news.laohu8.com/highlight/detail?id=2666060135","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666060135?lang=zh_tw&edition=fundamental","pubTime":"2026-09-12 16:32","pubTimestamp":1789201920,"startTime":"0","endTime":"0","summary":"2026年上半年，云南瑞丽产业协作园区陇川片区党工委、管委会以务实之举答好“招得来、留得住、发展好”这一课题，推动区域发展从“过路地”变“聚宝盆”。依托凯喜雅、德宏正信等龙头企业，园区集聚服装轻纺及关联企业9家，茧丝绸全产业链格局初步形成。截至7月底，陇川片区企业用工人数从8046人增至9291人，净增1245人。从通道到引擎，从蓝图到实景，陇川片区正以实干实效回应各方期待。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/wm/2026-09-12/doc-inirqfia5206901.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1593","02135","BK1209"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666852414","title":"時代天使(06699)授出合共156.39萬份受限制股份單位","url":"https://stock-news.laohu8.com/highlight/detail?id=2666852414","media":"智通财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666852414?lang=zh_tw&edition=fundamental","pubTime":"2026-09-11 20:27","pubTimestamp":1789129651,"startTime":"0","endTime":"0","summary":"时代天使(06699)发布公告，于2026年9月11日，本公司董事会决议根据首次公开发售后受限制股份单位计划向16名承授人(承授人)授予合共156.39万份受限制股份单位。","market":"sg","thumbnail":"https://img.zhitongcaijing.com/gonggaonew/ganggugongg41.jpg?x-oss-process=image/format,jpg/quality,Q_100/resize,h_300","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/gonggaonew/ganggugongg41.jpg?x-oss-process=image/format,jpg/quality,Q_100/resize,h_300"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1495215.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK1593","06699","BK1583","BK1587","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666258523","title":"復星醫藥(02196.HK)周五斥2,186萬元回購134萬股","url":"https://stock-news.laohu8.com/highlight/detail?id=2666258523","media":"阿斯达克财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666258523?lang=zh_tw&edition=fundamental","pubTime":"2026-09-11 17:49","pubTimestamp":1789120140,"startTime":"0","endTime":"0","summary":"复星医药(02196.HK) 公布，于9月11日回购134万股，每股作价介乎16.14至16.5元，涉资约2,186.42万元。(da)(港股报价延迟最少十五分钟。沽空资料截至 2026-09-11 16:25。)AASTOCKS新闻","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20250731211503309_s.png","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20250731211503309_s.png"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1544114/latest-news/AAFN","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1544114/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK0028","BK0175","BK1191","BK0012","BK0060","BK0239","BK0187","BK0096","600196","02196","BK0196","BK1515","BK0183","BK0188","BK1593"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666235705","title":"復星醫藥(600196.SH)子公司地舒單抗生物類似藥HLX14註冊申請獲受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2666235705","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666235705?lang=zh_tw&edition=fundamental","pubTime":"2026-09-11 17:44","pubTimestamp":1789119840,"startTime":"0","endTime":"0","summary":"智通财经APP讯，复星医药 发布公告，近日，公司控股子公司上海复宏汉霖生物技术股份有限公司及其控股子公司自主研发的地舒单抗生物类似药HLX14120mg/瓶规格的药品注册申请获国家药品监督管理局受理。此次申报适应症为其参照药安加维于中国境内已获批上市的所有适应症。据悉，HLX14为公司自主研发的地舒单抗生物类似药。截至公告日期，HLX14已分别于美国、欧盟、英国、加拿大获批上市。截至2026年8月，公司现阶段针对HLX14的累计研发投入约为3.52亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1495051.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["600196","PPH","BK0188","LU2272731865.HKD","BK4585","LU2473716301.USD","BK0187","BK0196","IE00B5TLWC47.USD","LU2272731782.SGD","XPH","BK1191","BK0175","BK0012","LU1992135399.USD","BK0096","02196","BK0183","BK0028","IBB","LU1992135472.HKD","BK0060","LU2322448957.HKD","LU2322448791.USD","BK1515","BK0239","BK4588","BK1593","LU2272731600.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666528460","title":"復星醫藥(02196)9月11日斥資約2186.42萬港元回購134萬股","url":"https://stock-news.laohu8.com/highlight/detail?id=2666528460","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666528460?lang=zh_tw&edition=fundamental","pubTime":"2026-09-11 17:36","pubTimestamp":1789119362,"startTime":"0","endTime":"0","summary":"智通财经APP讯，复星医药(02196)发布公告，于2026年9月11日该公司斥资约2186.42万港元回购134万股，回购价格为每股16.14至16.5港元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1495041.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","BK0187","600196","BK0028","BK1515","BK0239","02196","BK0188","BK0196","BK0012","BK0096","BK1593","BK0175","BK0183","BK0060"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666404595","title":"昊海生物科技：9月11日斥資40萬港元回購24300股","url":"https://stock-news.laohu8.com/highlight/detail?id=2666404595","media":"南方财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666404595?lang=zh_tw&edition=fundamental","pubTime":"2026-09-11 17:06","pubTimestamp":1789117560,"startTime":"0","endTime":"0","summary":"南财智讯9月11日电，昊海生物科技（06826.HK）发布翌日披露报表，公司于2026年9月11日在香港联合交易所进行股份回购，回购股份数量为24300股，每股最高回购价16.68港元，每股最低回购价16.31港元，付出的总代价为399865港元。回购股份拟注销，未持作库存股份。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609113872133540.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609113872133540.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1161","BK1593","06826"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666543626","title":"瑞麗醫美(02135)股價下跌6.612%，現價港幣$0.113","url":"https://stock-news.laohu8.com/highlight/detail?id=2666543626","media":"阿斯达克财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666543626?lang=zh_tw&edition=fundamental","pubTime":"2026-09-11 11:55","pubTimestamp":1789098900,"startTime":"0","endTime":"0","summary":"[下跌股]瑞丽医美(02135) 股价在上午11:54比前收市价下跌6.612%，现股价为港币$0.113。至目前为止，今日最高价为$0.116，而最低价为$0.113。总成交量为2万股，总成交金额为港币$2290。","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180205152747204_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180205152747204_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2609112418/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2609112418/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["02135","BK1209","BK1593"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666127155","title":"【券商聚焦】中信建投：醫療器械板塊業績有望逐步改善","url":"https://stock-news.laohu8.com/highlight/detail?id=2666127155","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666127155?lang=zh_tw&edition=fundamental","pubTime":"2026-09-11 09:18","pubTimestamp":1789089493,"startTime":"0","endTime":"0","summary":"金吾财讯 | 中信建投证券研究指，医疗器械板块Q2收入延续增长趋势，单季度利润增速四年来首次转正。该机构认为，随着集采影响逐步出清叠加创新驱动和海外业务加速的双重助力，医疗器械板块业绩有望逐步改善。尽管季度业绩增速可能有所波动，Q3能否相比Q2加速尚不确定，但大趋势来看，26和27年年度业绩持续改善的确定性较强。","market":"hk","thumbnail":"https://static.szfiu.com/news/20241108/MDc2YjQxZmY4Y2VkNWEzNDU4MmJiNGExMDgxOTA3MjUwMzc=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/MDc2YjQxZmY4Y2VkNWEzNDU4MmJiNGExMDgxOTA3MjUwMzc=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"299f0a9977df499f8ead781071e5e5e7","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1991348","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["159883","BK1587","GDOC","BK1142","BK1161","601066","IEIH","BK1593","06826","HART","LGHT","MEDX","AGNG","BK1222","BK1571","BK1247","09996","01066","PTH","BK1583","BK1600","KCE","LNGR","BK1515","BK1574","02252","00241","BK1615","00853","02190","BK1591","HK0000165453.HKD","LU0173614495.USD","01302","BK1502","MDEV","RSPH","BK0276","LU0287142896.SGD","02235","BK1610","BK1617","BK1584","BK1189","BK1585","BK1589","BK1100","BK1501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666917512","title":"【券商聚焦】中信證券：上半年CXO及生命科學上游板塊整體表現穩健，CRO有望量價齊升","url":"https://stock-news.laohu8.com/highlight/detail?id=2666917512","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666917512?lang=zh_tw&edition=fundamental","pubTime":"2026-09-11 09:07","pubTimestamp":1789088866,"startTime":"0","endTime":"0","summary":"金吾财讯 | 中信证券研究指，2026年上半年，CXO板块及生命科学上游板块整体业绩表现稳健，行业进入复苏阶段。上半年海外投融资景气度持续，美联储加息预期走弱，早研板块整体的景气度持续走强，AIDD的快速发展也将进一步催化未来相关实验和验证需求的爆发，该机构认为CRO板块有望量价齐升。CDMO板块上半年龙头业绩表现稳健，整体订单增速持续加快，行业景气度回升。","market":"nz","thumbnail":"https://static.szfiu.com/news/20250109/YmQzNzBkZGZmOTg1MzM5MTQzMTA0Ng==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/YmQzNzBkZGZmOTg1MzM5MTQzMTA0Ng==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"299f0a9977df499f8ead781071e5e5e7","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1991341","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KURE","02268","LU0348827113.USD","BK1574","03933","600030","WX","LU2328871848.SGD","KCE","LU0405327494.USD","06160","02228","IE00B3M56506.USD","BK0196","01099","LU1997245177.USD","SG9999004311.SGD","LU0561508036.HKD","06030","LU1997245094.SGD","02196","LU0463099449.HKD","BK1521","BK0028","LU2778985437.USD","LU0634319403.HKD","01789","LU0244354667.USD","09688","LU1997244956.HKD","09926","LU0348783233.USD","LU1720050803.USD","LU2476274308.USD","LU1188198961.HKD","CXO","BK0188","LU2495084118.USD","LU0417516902.SGD","02367","LU1969619763.USD","BK1500","SG9999014674.SGD","LU1794554557.SGD","06821","LU0540923850.HKD","LU1146622755.USD","BK1100","01530","BK1593"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666673645","title":"三生製藥(01530)9月10日斥資6262.93萬港元回購400萬股","url":"https://stock-news.laohu8.com/highlight/detail?id=2666673645","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666673645?lang=zh_tw&edition=fundamental","pubTime":"2026-09-10 18:36","pubTimestamp":1789036592,"startTime":"0","endTime":"0","summary":"智通财经APP讯，三生制药(01530)发布公告，于2026年9月10日，该公司斥资6262.93万港元回购400万股。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1494535.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["HK0000165453.HKD","BK1593","BK1583","BK1161","01530"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666610625","title":"昊海生物科技(06826)9月10日耗資約79.57萬港元回購4.8萬股","url":"https://stock-news.laohu8.com/highlight/detail?id=2666610625","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666610625?lang=zh_tw&edition=fundamental","pubTime":"2026-09-10 17:41","pubTimestamp":1789033302,"startTime":"0","endTime":"0","summary":"智通财经APP讯，昊海生物科技(06826)公布，2026年9月10日耗资约79.57万港元回购4.8万股股份。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1494472.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","06826","BK1593"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666060561","title":"昊海生物科技(06826.HK)9月10日耗資約79.57萬港元回購4.8萬股","url":"https://stock-news.laohu8.com/highlight/detail?id=2666060561","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666060561?lang=zh_tw&edition=fundamental","pubTime":"2026-09-10 17:41","pubTimestamp":1789033302,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1593","06826","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666549805","title":"復星醫藥(02196)股價下跌5.032%，現價港幣$16.42","url":"https://stock-news.laohu8.com/highlight/detail?id=2666549805","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666549805?lang=zh_tw&edition=fundamental","pubTime":"2026-09-10 10:54","pubTimestamp":1789008840,"startTime":"0","endTime":"0","summary":"[下跌股]复星医药(02196) 股价在上午10:53比前收市价下跌5.032%，现股价为港币$16.42。至目前为止，今日最高价为$17.2，而最低价为$16.42。总成交量为368.176万股，总成交金额为港币$6.135千万。","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180725133905145_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180725133905145_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2609101759/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2609101759/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["600196","BK0196","BK0060","BK0183","BK0239","BK0012","BK0188","BK1515","02196","BK0175","BK1593","BK0187","BK0028","BK0096","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666554961","title":"三生製藥(01530)出現大手賣出56.2萬股，成交價$15.6，涉資876.72萬","url":"https://stock-news.laohu8.com/highlight/detail?id=2666554961","media":"阿斯达克财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666554961?lang=zh_tw&edition=fundamental","pubTime":"2026-09-10 10:53","pubTimestamp":1789008780,"startTime":"0","endTime":"0","summary":"[大手成交]三生制药(01530)在上午10:53出现大手卖出，成交量为56.2万，成交价为港币$15.6，涉资876.72万。至目前为止，股价跌3.344%，今日最高价为$16.12，而最低价为$15.6，总成交量为1.626千万股，总成交金额港币$2.554亿。","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180205145550051_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180205145550051_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAT2609104122/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAT2609104122/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["01530","BK1593","BK1583","BK1161","HK0000165453.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666368551","title":"四環醫藥(00460)出現大手賣出210萬股，成交價$0.73，涉資153.3萬","url":"https://stock-news.laohu8.com/highlight/detail?id=2666368551","media":"阿斯达克财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666368551?lang=zh_tw&edition=fundamental","pubTime":"2026-09-10 09:45","pubTimestamp":1789004700,"startTime":"0","endTime":"0","summary":"[大手成交]四环医药(00460)在上午09:45出现大手卖出，成交量为210万，成交价为港币$0.73，涉资153.3万。至目前为止，股价跌4.516%，今日最高价为$0.775，而最低价为$0.73，总成交量为2.484千万股，总成交金额港币$1.856千万。","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180126132514810_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180126132514810_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAV2609101869/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAV2609101869/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1515","BK1600","BK1593","BK1191","00460"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666539022","title":"多家藥企處置資產反哺主業","url":"https://stock-news.laohu8.com/highlight/detail?id=2666539022","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666539022?lang=zh_tw&edition=fundamental","pubTime":"2026-09-09 22:59","pubTimestamp":1788965940,"startTime":"0","endTime":"0","summary":"除此之外，今年以来，多瑞医药先后将厦门瑞蒂莲69%股权转让给关联方西藏嘉康时代科技发展有限公司，属于首批处置的非核心资产；为了剥离低效制剂相关业务，多瑞医药还将湖北海瑞迪100%股权全部转让给关联方西藏嘉康。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hyyj/2026-09-09/doc-inirfytq8374634.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["02196","BK1191","09939","BK1574","BK1161","BK1593","BK1515","BK4202","FOSL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666538734","title":"復星醫藥白癜風口服新藥獲批III期臨床","url":"https://stock-news.laohu8.com/highlight/detail?id=2666538734","media":"健识局","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666538734?lang=zh_tw&edition=fundamental","pubTime":"2026-09-09 19:42","pubTimestamp":1788954120,"startTime":"0","endTime":"0","summary":"近日，复星医药宣布，FXS5626片（原项目代号：AC-201）用于治疗非节段型白癜风开展II/III期适应性无缝设计临床试验已获药监局批准。从进度看，辉瑞利特昔替尼和诺诚健华soficitinib处于第一梯队，均已公布积极II/III期数据。复星医药FXS5626与华东医药VC005、恒瑞艾玛昔替尼大致处于第二梯队。 且国内白癜风口服在研管线中，FXS5626是目前唯一明确标注为TYK2/JAK1双靶点的品种。运营｜廿十三","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/hk/2026-09-09/doc-inirfums8444408.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["600196","02196","BK0239","BK1191","BK0175","BK0188","BK0096","BK1515","BK0183","BK1593","BK0012","BK0060","BK0028","BK0187","BK0196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666843785","title":"復星醫藥(02196)9月9日斥資262.98萬港元回購15.25萬股","url":"https://stock-news.laohu8.com/highlight/detail?id=2666843785","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666843785?lang=zh_tw&edition=fundamental","pubTime":"2026-09-09 18:03","pubTimestamp":1788948238,"startTime":"0","endTime":"0","summary":"智通财经APP讯，复星医药(02196)发布公告，于2026年9月9日，该公司斥资262.98万港元回购15.25万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1493968.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1515","BK0012","BK0187","BK0096","BK0175","BK0188","BK0060","600196","BK0196","02196","BK1191","BK0028","BK1593","BK0239","BK0183"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666058130","title":"康哲藥業(00867.HK)狂犬雙特異性抗體「金速希」全國首批處方落地","url":"https://stock-news.laohu8.com/highlight/detail?id=2666058130","media":"阿斯达克财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666058130?lang=zh_tw&edition=fundamental","pubTime":"2026-09-09 17:28","pubTimestamp":1788946080,"startTime":"0","endTime":"0","summary":"康哲药业公布，一类创新药“金速希”近日在全国多地开出首批处方，覆盖首都医科大学附属北京潞河医院、温州市人民医院等多家医疗机构，标志着全球首款狂犬病被动免疫双特异性抗体正式进入规模化临床应用。","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20230303150406244_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20230303150406244_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1543675/latest-news/AAFN","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1543675/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["SG9999015986.USD","SG9999004220.SGD","00867","BK1593","IE00BVYPNP33.GBP","SG9999015952.SGD","SG9999015978.USD","LU2488822045.USD","IE00BMCWC346.EUR","IE00BVYPNQ40.USD","BK1191","SG9999004311.SGD","IE00BYV24P56.USD","IE00BGHQDM52.EUR","SG9999015945.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666304134","title":"《大行》里昂：中國創新藥板塊重返Alpha主導  宏觀波動或提供買入機會","url":"https://stock-news.laohu8.com/highlight/detail?id=2666304134","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666304134?lang=zh_tw&edition=fundamental","pubTime":"2026-09-09 12:08","pubTimestamp":1788926880,"startTime":"0","endTime":"0","summary":"里昂发表报告指，中国创新药板块正重回以公司基本面与个股超额收益为主导的市场，公司特定基本面相对宏观因素的影响力回升。该行预期，随市场对创新药企临床及BD执行信心改善，基本面角色将愈趋重要；短期宏观波动或提供趁低买入、验证此观点的机会。该行认为，重大临床读出与BD活动加速，正面催化剂窗口正在打开。","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20220210100852532_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20220210100852532_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1543577/latest-news/AAFN","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1543577/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["LU2399975544.HKD","LU1152091168.USD","SG9999015986.USD","LU0320764599.SGD","IE00BPRC5H50.USD","LU2097828557.USD","BK1583","BK1576","01276","LU0417516902.SGD","01801","BK1515","LU1046422090.SGD","LU1820825898.SGD","BK1500","LU0348825331.USD","BK0196","BK1593","LU1813983027.USD","LU2148510915.USD","LU1188198961.HKD","09926","LU1226287792.SGD","LU2045819591.USD","LU2289578879.USD","600276","LU0348735423.USD","BK1191","KURE","LU1960683339.HKD","IE00BYV24P56.USD","LU0314109678.HKD","SG9999015978.USD","LU2580892862.HKD","01093","LU0880133367.SGD","01099","LU2039709279.SGD","LU1997244956.HKD","IE00BMCWC346.EUR","SG9999004311.SGD","BK1574","LU0463099449.HKD","BK0188","LU1794554557.SGD","IE0008369823.USD","603259","LU1255011170.USD","LU0326950275.SGD","IE00B543WZ88.USD","LU0348766576.USD","IE00BZ08YS42.EUR","LU1064130708.USD","SG9999015952.SGD","LU2476274308.USD","LU1961090484.USD","LU0348827113.USD","LU0067412154.USD","LU1226287529.USD","LU0561508036.HKD","BK1141","LU0327786744.USD","LU1152091754.HKD","LU2125910500.SGD","HK0000165453.HKD","LU0572944931.SGD","BK1197","LU1655091616.SGD","LU0072913022.USD","BK0183","LU0052750758.USD","LU0348767384.USD","LU0501845795.SGD","LU0149534421.HKD","LU0540923850.HKD","LU1831875114.USD","LU2495084118.USD","LU0405327148.USD","LU0348784397.USD","BK1161","LU0455707207.USD","LU0244354667.USD","BK1589","01177","LU1993786604.SGD","LU2476274720.SGD","LU1115378108.SGD","SHTDY","LU1328615791.USD","LU1807302812.USD","LU1064131003.USD","02595","IE00BVYPNQ40.USD","LU1969619763.USD","LU0315179316.USD","LU1720050803.USD","LU0469268626.HKD","LU1997245094.SGD","IE00BZ08YT58.USD","03692","LU2488822045.USD","IE00BVYPNP33.GBP","00867","IE00B5MMRT66.SGD","LU0607220059.USD","BK0060","LU0140636845.USD","LU2097828474.EUR","BK0114","LU0634319403.HKD","LU0708995583.HKD","LU1328277881.USD","02359","LU1997245177.USD","LU2242644610.SGD","BK0239","IE00BZ08YR35.GBP","BK1521","LU2097828631.EUR","LU2778985437.USD","LU2328871848.SGD","LU1580142542.USD","LU0417516571.SGD","LU0417516738.SGD","LU0348783233.USD","IE00BGHQDM52.EUR","LU0405327494.USD","BK0185","LU2580892789.USD","LU0640798160.USD","SG9999015945.SGD","LU1951186391.HKD","LU1226288170.HKD","LU1226288253.USD","IE0008368742.USD","SG9999004220.SGD","02162","LU0502904849.HKD","LU1781817850.SGD","BK1587","300765","SBHMY","603233","BK0226","BK0012","LU1226287875.USD","LU2097828714.EUR","BK0028","LU1146622755.USD","BK0209","IE00B031HY20.USD","LU1008478684.HKD","LU2097828805.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":1,"totalSize":72,"code":"91000000","status":"200"}]}}